Covid-19 Tests

Our Easy Process

How to Get Your Test Done

covid19 testing online

Fill out our quick and easy registration form online or with our QR code.

pexels andrea piacquadio 3756345 scaled

Make your payment online or pay cash upon arrival. Save or print your emailed receipt.

wait in car

Check in with your QR code upon arrival. Wait in your car.

Please Select Your Covid-19 Test Type Below

Rapid Antigen Test:

The tests detect specific proteins — known as antigens — on the surface of the virus, and can identify people who are at the peak of infection, when virus levels in the body are likely to be high. This test is very accurate but not approved by most airlines for travel.

Cost: $150  |  Results: 15 Minutes
PCR Swab:

This test is to detect if you have active viral SARS CoV-2 using Real Time (RT) Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). This test is considered the gold standard and the most reliable way to detect for the coronavirus.

Cost: Free  |  Results: 24 – 48 Hrs
Insurance Reimbursement Form

We provide an HCFA1500 insurance reimbursement form (below) for you to pursue reimbursement from your insurance*

For the insurance reimbursement form please click button below:

How is the test conducted?

  • Rapid Antigen– A nasopharyngeal swab is performed. The sample is run on a cartridge and results are delivered in as little as15 minutes
  • PCR Swab – A minimally invasive nasopharyngeal swab
  • Rapid Antibody – The test is conducted through finger prick to identify the IgG/IgM antibodies
  • Flu/Covid-19 combo – A minimally invasive nasopharyngeal swab
same day drive thru covid 19 testing 2
Granada Hills 91344Porter Ranch91326
Mission Hills91345Northridge91325
North Hills91343Northridge91324
Newhall91321San Fernando91340
Panorama City91402Pacoima91331
Reseda91335Van Nuys91406
Los AngelesSimi Valley
San Fernando valleyAntelope Valley


11460 Porter Ranch Dr
Porter Ranch, CA 91326

covid tests summary

Covid-19 PCR Diagnostic

The emergence of SARS-CoV-2 was unforeseen, and the worldwide outbreak of COVID-19 has already impacted millions. In response to the desperate public need for rapid high-volume testing we developed SARS-CoV-2 assays on both our Panther® and Panther Fusion® systems.* Both assays enable labs to run over 1000 tests in 24 hours and attain first results in 3.5 hours or less.1†

The Panther Fusion® SARS-CoV-2 assay is a real-time PCR test and the Aptima® SARS-CoV-2 assay utilizes our proprietary TMA® technology. Both assays are intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens (Panther Fusion assay only) obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria.2,3

TaqPath COVID-19 Multiplex Diagnostic Solution

Covid-19 PCR Diagnostic

In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection. The Applied Biosystems TaqPath COVID-19 kit is a fast, highly sensitive multiplex diagnostic solution that contains both the assays and controls needed for the real-time PCR detection of RNA from the SARS-CoV-2 virus.

Illumina COVIDSeq Test

Covid-19 PCR Diagnostic

This high-throughput next-generation sequencing (NGS) test detects SARS-CoV-2 in nasopharyngeal, oropharyngeal, and mid-turbinate nasal swabs from patients suspected of COVID-19.

Key Features and Benefits
  • Accuracy: Detects 98 targets on SARS-CoV-2 for highly accurate detection
  • Quality Control: Internal control consists of 11 human mRNA targets in every reaction
  • Flexibility: Available on NovaSeq 6000 S4 and SP flow cells and on NextSeq 500/550/550Dx (in RUO mode) HO flow cell

Covid-19 Antigen

Rapid Diagnostic Test for the Detection of SARS-CoV-2 Antigen

The CareStart™ COVID-19 Antigen test is a lateral flow immunochromatographic
assay intended for the qualitative detection of the
nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal
swab specimens directly collected, or collected in BD universal
transport media, from individuals suspected of COVID-19 by their
healthcare provider within five days of symptom onset. Testng is
limited to laboratories certified under the Clinical Laboratory
Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that
meet the requirements to perform moderate, high, or waived
complexity tests. This test is authorized for use at the Point of Care
(POC), i.e., in patient care settings operatingng under a CLIA Certificate
of Waiver, Certificate of Compliance, or Certificate of Accreditation.

View Informational Handout Here.